Will Life Sciences Companies Face More Scrutiny In 2018?
The pace of U.S. Department of Justice settlements with life sciences companies slowed in 2017, with nine companies resolving criminal or civil allegations under various federal health care fraud laws. While...To view the full article, register now.
Already a subscriber? Click here to view full article